Skip to Content

Tag: Insulin

Also Noted

Ascensia supports Spare a Rose campaign

February 11, 2021HME News Staff

BASEL, Switzerland – Ascensia Diabetes Care is supporting the 2021 Spare a Rose campaign, which encourages people to donate the $5 cost of each rose they would have given someone on Valentine’s Day to Life for a Child. The organization provides lifesaving diabetes supplies and insulin to children in countries such as Mauritania, Jamaica and India. “While people around the world will be buying flowers and cards for their loved on this Valentine’s Day, many of...

Ascensia, Diabetes, Insulin, Spare a Rose Campaign

Read Full Articlered right arrow icon

Specialty Providers

Medtronic seeks to integrate CGM, smart pen

September 25, 2020Theresa Flaherty, Managing Editor

DUBLIN, Ireland - Although Medtronic is a leader in insulin pump technology, the majority of people with diabetes who use insulin still opt for injections—that's why the company wants to “close the loop” for those patients. In August, Medtronic announced it had acquired Companion Medical, the manufacturer of?InPen, a smart insulin pen system paired with an integrated diabetes management app that helps with insulin dosing and tracking. “It became apparent to us there was a...

CGM, Insulin, Medtronic, smart pen, technology

Read Full Articlered right arrow icon


Medicare Advantage: CMS touts reduced premiums, increased access

September 25, 2020HME News Staff

WASHINGTON - The Medicare Advantage average monthly plan premium is expected to decrease 11% to $21 in 2021, CMS has announced. Since 2017, the average monthly plan premium has decreased 34.2%, according to the agency, saving beneficiaries nearly $1.5 billion in costs. “This is the lowest that the average monthly premium for a Medicare Advantage plan has been since 2007,” CMS state. “In some states, including Alabama, Nevada, Michigan and Kentucky, beneficiaries will see average...

Insulin, Medicare Advantage, Premiums, Telehealth

Read Full Articlered right arrow icon

Also Noted

Plans buy into insulin savings model

May 27, 2020HME News Staff

WASHINGTON - More than 1,750 standalone Medicare Part D prescription drug plans and Medicare Advantage plans with prescription drug coverage have applied to offer lower insulin costs through the Part D Senior Savings Model for 2021. Across the nation, participating enhanced Part D prescription drug plans will provide Medicare beneficiaries access to a broad set of insulins at a maximum $35 co-pay for a month's supply from the beginning of the year through the Part D coverage gap. Based on CMS's estimates,...

Diabetes, Insulin, savings

Read Full Articlered right arrow icon

Also Noted

New law caps insulin co-pays at $100

May 28, 2019HME News Staff

DENVER - Colorado Gov. Jared Polis has signed a new law that caps co-payments for prescription insulin to $100 a month for insured patients, regardless of the amount or type of drug needed. The law also directs the state's attorney general to investigate pricing of insulin drugs and determine whether or not additional consumer protections are needed. Colorado is the first state to enact such a law, according to news reports. Almost 20,000 Coloradans are diagnosed with diabetes each year and as of...

Cost, Insulin

Read Full Articlered right arrow icon

Also Noted

Abbott, Novo Nordisk seek to eliminate 'hassle'

February 20, 2019HME News Staff

ABBOTT PARK, Ill. - Abbott and Novo Nordisk have partnered to integrate insulin dose data from Novo Nordisk's connected insulin pens with digital health tools compatible with Abbot's FreeStyle Libre continuous glucose monitoring system. The integration will allow healthcare professionals, caregivers and patients to view glucose and insulin data together to help them make better informed treatment decisions, according to a press release. "It is our aim at Abbott to continuously provide life-changing...

Abbott, FreeStyle Libre, Insulin, Novo Nordisk

Read Full Articlered right arrow icon

Also Noted

Companion Medical launches insulin pen app

January 25, 2019HME News Staff

SAN DIEGO - Companion Medical has launched the Android version of its InPen App, a smart insulin pen system that helps users manage dosages and provides reports that display aggregated glucose, insulin and meal data. "Our mission is to empower people living with diabetes and their healthcare providers with easy-to-use connected solutions that improve outcomes at a lower cost,” said CEO Sean Saint, in a press release. “InPen's dose calculator, insulin-on-board tracking, and dose reminders...

Companion Medical, Diabetes, InPen App, Insulin

Read Full Articlered right arrow icon

Also Noted

Insulin use to increase, study finds

November 29, 2018HME News Staff

NEW YORK - The amount of insulin required to treat Type 2 diabetes is expected to increase by more than 20% from 2018 to 2030, according to a new study published in The Lancet. Using data from the International Diabetes Federation, researchers developed a microsimulation of the Type 2 diabetes burden across 221 countries. The number of people worldwide with Type 2 diabetes is estimated to increase from 405.6 million in 2018 to 510.8 million in 2030. Insulin use is estimated to increase 616.1 million...

Access, Diabetes, Insulin

Read Full Articlered right arrow icon

Also Noted

Insulet reduces net loss

August 3, 2018HME News Staff

BILLERICA, Mass. - Insulet Corp., maker of the Omnipod Insulin Management System, reported revenues of $124.3 million for the second quarter, a 13% increase compared to the same period last year. It reported revenues of $78.1 million for the Omnipod in the U.S., a 19% increase. Insulet reported a net loss of $1.7 million for the second quarter compared to a net loss of $7.8 million for the same period last year. Among the company's highlights in the second quarter: It assumed direct European operations...

Financial Results, Insulet, Insulin, OmniPod

Read Full Articlered right arrow icon

Also Noted

ADA: Improve insulin access, affordability

May 31, 2018HME News Staff

ARLINGTON, Va. - The American Diabetes Association on May 24 released a public policy statement outlining both long- and short-term recommendations for improving insulin access and affordability. The recommendations in “ADA Public Policy Statement: Insulin Access and Affordability” include increasing transparency across the entire insulin supply chain; streamlining the approval process for biosimilar insulins; lowering or removing patient cost-sharing for insulin; and increasing...

ADA, Diabetes, Insulin, Policy

Read Full Articlered right arrow icon